+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

2019 T-Cell Leukemia Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • PDF Icon

    Report

  • 255 Pages
  • April 2019
  • Region: Global
  • VPA Research
  • ID: 4767974
UP TO OFF until Jan 05th 2023
The global clinical trial report- “2019 T-Cell Leukemia Clinical Trials Study” provides complete list of trials completed, ongoing and planned for T-Cell Leukemia. It presents in-depth analysis of T-Cell Leukemia clinical trials across markets and companies. The research work is for providing complete understanding into trends in T-Cell Leukemia.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the T-Cell Leukemia clinical trials by:
  • Current Trial Status

  • Type of the trial

  • Sponsor Type

  • Enrollment Trends

  • Region

  • Countries

  • Trial Phase



The report also identifies the potential drug candidates under development for treatment of T-Cell Leukemia

The research work is prepared through extensive and continuous research on T-Cell Leukemia trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.

  • Drug candidates currently being researched for administering T-Cell Leukemia patients are identified

  • The report includes panorama of T-Cell Leukemia clinical trials across the globe

  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided

  • Companies and universities focusing on T-Cell Leukemia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)

  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included

  • Both interventional and observational studies are analyzed

  • News and latest developments for the past one year are presented in the report

Table of Contents

1.1 List of Figures1.2 List of Tables
2. Executive Summary
2.1 T-Cell Leukemia Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 T-Cell Leukemia Clinical Trials by Region
2.2.2 Average Enrollment of T-Cell Leukemia Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for T-Cell Leukemia Treatment, 2019
3. Region wise T-Cell Leukemia Clinical Trials
3.1 Asia Pacific T-Cell Leukemia Clinical Trials by Country
3.2 Europe T-Cell Leukemia Clinical Trials by Country
3.3 North America T-Cell Leukemia Clinical Trials by Country
3.4 Middle East and Africa T-Cell Leukemia Clinical Trials by Country
3.5 South and Central America T-Cell Leukemia Clinical Trials by Country
4. T-Cell Leukemia Clinical Trial Trends
4.1 Start Year wise T-Cell Leukemia Clinical Trials
4.2 Phase wise T-Cell Leukemia Clinical Trials
4.3 Trial Status wise T-Cell Leukemia Clinical Trials
4.4 Trial Type wise T-Cell Leukemia Clinical Trials
5. T-Cell Leukemia Average Enrollment Trends
5.1 Average Enrollment in T-Cell Leukemia Trials by Year
5.2 Average Enrollment in T-Cell Leukemia Trials by Phase
5.3 Average Enrollment in T-Cell Leukemia Trials by Status
5.4 Average Enrollment in T-Cell Leukemia Trials by Type of Trial
6. Companies Participating in T-Cell Leukemia Clinical Trials
6.1 T-Cell Leukemia Trials by Sponsor Type
6.2 T-Cell Leukemia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 T-Cell Leukemia Trials- Phase 1
7.2 T-Cell Leukemia Trials- Phase 2
7.3 T-Cell Leukemia Trials- Phase 3
7.4 T-Cell Leukemia Trials- Phase 4
8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
List of Figures
Figure 1: T-Cell Leukemia Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise T-Cell Leukemia Clinical Trials and Enrolment
Figure 5: Europe - Country wise T-Cell Leukemia Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise T-Cell Leukemia Clinical Trials and Enrolment
Figure 7: North America - Country wise T-Cell Leukemia Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise T-Cell Leukemia Clinical Trials and Enrolment
Figure 9: T-Cell Leukemia Clinical Trials by Phase
Figure 10: T-Cell Leukemia Clinical Trials by Trial Status
Figure 11: T-Cell Leukemia Clinical Trials by Type
Figure 12: T-Cell Leukemia Clinical Trials by Sponsor Type
Figure 13: T-Cell Leukemia Clinical Trials by Leading Sponsors
Figure 14: T-Cell Leukemia Average Enrollment by Phase
Figure 15: T-Cell Leukemia Average Enrollment by Trial Status
Figure 16: T-Cell Leukemia Average Enrollment by Type
Figure 17: T-Cell Leukemia- Average Enrolment by Type of Sponsors
Figure 18: T-Cell Leukemia- Enrolment by Leading Sponsors
Figure 19: Research Methodology
List of Tables
Table 1: T-Cell Leukemia Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise T-Cell Leukemia Clinical Trials and Enrolment
Table 5: Europe - Country wise T-Cell Leukemia Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise T-Cell Leukemia Clinical Trials and Enrolment
Table 7: North America - Country wise T-Cell Leukemia Clinical Trials and Enrolment
Table 8: South and Central America - Country wise T-Cell Leukemia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: T-Cell Leukemia Average Enrollment by Phase
Table 15: T-Cell Leukemia Average Enrollment by Trial Status
Table 16: T-Cell Leukemia Average Enrollment by Type
Table 17: T-Cell Leukemia- Average Enrolment by Type of Sponsors
Table 18: T-Cell Leukemia- Enrolment by Leading Sponsors

Companies Mentioned

  • AbbVie Inc

  • AstraZeneca Plc

  • BioCryst Pharmaceuticals Inc

  • Bioniz Therapeutics Inc

  • Celgene Corp

  • GlaxoSmithKline Plc

  • Kirin Holdings Co Ltd

  • Novartis AG

  • Seattle Genetics Inc

  • Takeda Pharmaceutical Co Ltd